Amanote Research
Register
Sign In
P1.15-33 Real-World Data on Prognostic Factors for Overall Survival in NSCLC Patients Treated With Bevacizumab Combination Therapy
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.966
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
S. Wu
W. Liao
C. Ho
J. Shih
C. Yu
Publisher
Elsevier BV